Abstract:
The superconductivity properties of superconducting compounds are controlled or maintained by active external electrochemical intervention. The superconducting compound forms one electrode (12) in the electrochemical cell (10). A counterelectrode (14) and the superconducting compound electrode (12) are in contact with an electrolyte (16) and a potential is applied between the counterelectrode (14) and the superconducting electrode (12). The cell is operated at a temperature near the expected transition temperature of the superconducting material. The potential applied between the electrodes is selected to control a property such as transition temperature. In a preferred embodiment, a superconducting material such as Ba2YCu3O7-x serves as an anode (12) and a counterelectrode (14) such as a mercury-mercuric oxide reference electrode serves as a cathode. Suitable oxygen-bearing electrolytes are ozone and trifluoronitrosomethane. In another embodiment, a superconducting cuprate material serves as a cathode and the electrolyte is copper-bearing.
Abstract:
The present invention is a method to produce polysaccharides with altered functional groups on their surface having modified surface charge as a result of the altered functional groups. These functional groups include, but are not limited to, negatively charged pyruvyl and succinyl moieties and positively charged amino groups. The polysaccharides can be produced by either: (1) mutation and selection of organisms synthesizing polysaccharides with modified surface charge or (2) engineering of specific genes within organisms to alter the charged groups attached to the polysaccharides during synthesis. Mutation of Zoogloea ramigera polysaccharide, as measured by the change in pyruvate content, is demonstrated. The isolation, characterization and manipulation of the gene for the pyruvyl transferase enzyme, which adds pyruvyl moities to the exopolysaccharide produced by Zoogloea ramigera, leading to an exopolysaccharide having a modified surface charge, is detailed. The modified exopolysaccharides have new applications due to the differences in surface charge. The modified enzymes and sequences regulating their expression can be used to produce novel polysaccharides. Further, studies of the structural-functional relationships of the modified exopolysaccharide can lead to a better understanding of secondary and tertiary structure in polysaccharides.
Abstract:
A new III-V buffer material is described which is produced by low temperature growth of III-V compounds by MBE that has unique and desirable properties, particularly for closely spaced, submicron gate length active III-V semiconductor devices, such as HEMT's, MESFET's and MISFET's and also for ultra-high-speed photoconductor swicthing devices. In the case of the III-V material, GaAs, the buffer is grown under arsenic stable growth conditions, at a growth rate of 1 micron/hour, and at a substrate temperature preferably in the range of 150 to about 300°C. The new material is crystalline, highly resistive, substantially optically inactive, and can be overgrown with high quality III-V active layers.
Abstract:
An osmium-catalyzed method of addition to an olefin. In the method of asymmetric dihydroxylation of the present invention, an olefin, a chiral ligand, an organic solvent, water, an amine oxide, an osmium-containing compound and, optionally a tetraalkyl ammonium compound are combined. In the method of asymmetric oxyamination of the present invention, an olefin, a chiral ligand, an organic solvent, water, a metallochloramine derivative, an osmium-containing compound and, optionally, a tetraalkyl ammonium compound are combined. In the method of asymmetric diamination of the present invention, an olefin, a chiral ligand, an organic solvent, a metallochloramine derivative, an amine and an osmium-containing compound are combined. In one embodiment, an olefin, a chiral ligand which is a dihydroquinidine derivative or a dihydroquinine derivative, acetone, water, N-methyl morpholine N-oxide and osmium tetroxide are combined to effect asymmetric dihydroxylation of the olefin.
Abstract:
Compositions useful in the treatment of disturbances of appetite, disturbances of mood, or both, associated with premenstrual syndrome, as well as methods of use therefor. The compositions include serotoninergic drugs, such as d-fenfluramine and fluoxetine.
Abstract:
A class of unsaturated polyanhydrides having double bonds available for secondary polymerization is disclosed. A crosslinked material having improved or different physical and mechanical properties can be prepared from these polyanhydrides, via secondary polymerization. The synthesis and characteristics of one unsaturated polyanhydride based on fumaric acid and its copolymers with aliphatic and aromatic diacids, prepared by either the melt-polycondensation method or by solution polymerization, is described in detail. These polymers are well suited for use in controlled release drug delivery devices. The polymers can also be used as a bioerodible bone cement where the polymer is first cast as a solution onto a bone fracture and then crosslinked by radiation or radical polymerization to yield a strong, adhesive material.
Abstract:
New soluble preceramic polymers formed by reacting B10H14-nRn, (where R is a lower alkyl group having from 1 to about 8 carbon atoms, a substituted or unsubstituted cycloalkyl group having from 3 to about 8 carbon atoms, a substituted or unsubstituted lower alkenyl group having from 2 to about 8 carbon atoms, or a substituted or unsubstituted lower aryl group having from 6 to about 10 carbon atoms, and n is a number from zero to about six) with a diamine in an organic solvent are disclosed. Preferably the diamine has the formula R1R2N-R3-NR4R5 where R1, R2, R4 and R5 are H, a lower alkyl group having from 1 to about 8 carbon atoms, a substituted or unsubstituted cycloalkyl group having from 3 to about 8 carbon atoms, a substituted or unsubstituted lower alkenyl group having from 2 to about 8 carbon atoms, a substituted or unsubstituted lower aryl group having from 6 to about 10 carbon atoms, or a di- or triorganosilyl. R3 is a lower alkylene group having from 1 to about 8 carbon atoms, a substituted or unsubstituted cycloalkylene group having from 3 to about 8 carbon atoms, a substituted or unsubstituted lower alkenylene group having from 2 to about 8 carbon atoms, a substituted or unsubstituted lower arylene group having from 6 to about 10 carbon atoms, a subsitituted or unsubstituted group, a heteroatom-containing cycloalkylene group, a heteroatom-containing alkenylene group, or a heteroatom-containing arylene group. A method of using Lewis base adducts of decarborane of the formula B10H12-nRn.2L, where R and n are as defined above and L is any neutral Lewis base, can be used as binders for ceramic powders is also disclosed. And a method of using these Lewis base adducts as precursors in forming shaped ceramic bodies is also described.
Abstract:
A method of producing interlayer conductive paths having substantially planar top surfaces in a multilayer integrated circuit structure (IC), comprising the steps of forming elements of either a conductive or semiconductive material (M1) as a lower layer, depositing an insulative layer (I2) on top of the lower layer elements (S), implanting ions into one or more selected regions (V) of the insulative layer, forming at least one upper conductor (M2) over the selected regions and sintering the integrated circuit structure sufficient to render the selected regions conductive. The invention also embraces an integrated circuit structures with interlayer conductive paths (M1 and M2) made in accordance with this method.
Abstract:
A biologically active substance, e.g. a therapeutic agent, is delivered from an inorganic polymeric system including a polyphosphazene polymer body, the active substance being physically entrapped by the polymer body. When the system is exposed to an aqueous fluid, e.g. when implanted in physiological fluid of a living mammal, the agent is released from the polymer body at a sustained and controlled rate.
Abstract:
A system comprising heparinase to degrade polydispersed low molecular weight heparin fractions and fragments (LMHF) both in vitro and in vivo. In vitro data show that both the APTT and anti-FXa activities of LMHF, including Kabi 2165, PK 10169, CY 216 and CY 222, are nearly completely eliminated by heparinase in less than 20 minutes, even when the LMHF are present at a level ten times greater than normally used clinically.